openPR Logo
Press release

Stendomycin Salicylate Market share will expand till 2024

01-22-2018 03:19 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Stendomycin Salicylate Market share will expand till 2024

A new research report by Transparency Market Research offers a comprehensive evaluation of the global Stendomycin Salicylate Market. The study, titled “Stendomycin Salicylate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”, is available for sale on the firm’s website.

Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of the disease-causing fungus is Sphaerotheca pannosa var. rosae. The fungus is also known as Podosphaera pannosa. Rose mildew is a highly common foliar disease of roses. The visible white powdery growth can affect all parts of the plant that are above the ground. Poor-quality soil, high humidity, and lack of oxygen for plants are favorable conditions for this disease. It can hamper the growth and quality of the rose plant badly. The disease attacks rose plants primarily in summer, as the climatic conditions are favorable for growth of the fungus in summer. Stendomycin salicylate has been found to be highly effective in controlling the rose mildew disease.

View Report Preview:
https://www.transparencymarketresearch.com/stendomycin-salicylate-market.html

The synthesis of stendomycin salicylate is in a novice phase, with most of the research and development done on rose plants. The plants have demonstrated good response to the use of stendomycin salicylate and research has proved to be successful in controlling the disease. The market for stendomycin salicylate is still in infancy and so far, the antibiotic has not been produced commercially. Once manufactured commercially, stendomycin salicylate can witness significant demand across the globe.

High demand for rose flower plants across the globe is expected to drive the stendomycin salicylate market. Rose is one of the most consumed flowers, due to its high use, especially in festive and marriage seasons. Cut flowers of rose are also used for decoration on various festive occasions. Stendomycin salicylate can also be applied on other foliar plants such as lily, jasmine, and marigold.

Based on region, the stendomycin salicylate market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is expected to hold a significant share of the stendomycin salicylate market during the forecast period. This is due to high demand for rose flower coupled with large production of cut flowers in the region. The Netherlands is one of the leading producers of cut flowers such as rose in the region. The country also hosts one of the leading markets for flowers in the world. North America is expected to follow Europe during the forecast period.

Countries in Europe such as Sweden, Denmark, and Switzerland also produce roses in considerable numbers, which drives the demand for stendomycin salicylate in the region. The market in the region is anticipated to be driven by high demand for roses in almost all seasons, especially festive seasons. Asia Pacific is likely to follow North America. The stendomycin salicylate market in Asia Pacific is expected to expand at a rapid pace in the next few years, due to large consumer base in the region. Markets in Latin America and Middle East & Africa are also expected to expand at a steady pace during the forecast period. Countries in Africa such as Kenya and Ethiopia also produce cut flowers. This, in turn, is anticipated to raise the demand for stendomycin salicylate in Middle East & Africa.

Being at a novel phase, the stendomycin salicylate market is undergoing research and development activities. Companies that deal in the manufacture of antifungal antibiotics are leading the research and development of stendomycin salicylate. Major players operating in the global stendomycin salicylate market are Lily Research Laboratories, GlaxoSmithKline, Pfizer, Merck, Eli Lily & Co., and National Institute of Allergy and Infectious Diseases.

Request to view Sample Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20771

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stendomycin Salicylate Market share will expand till 2024 here

News-ID: 911739 • Views:

More Releases from Transparency Market Research

Inflatable Dome Industry Set for Significant Growth: CAGR of 6.2% Predicted Through 2034
Inflatable Dome Industry Set for Significant Growth: CAGR of 6.2% Predicted Thro …
The inflatable dome market, a unique convergence of engineering and architecture, is on a significant growth trajectory. Valued at US$ 1.3 billion in 2023, the market is projected to grow at a CAGR of 6.2% during the forecast period of 2024 to 2034, reaching an estimated value of US$ 2.4 billion by the end of 2034. This rapid growth is driven by the versatility, cost-effectiveness, and sustainability of inflatable domes,
Global Corporate Travel Security Market to Reach $19 Billion by 2034 Amid Rising Safety Concerns for Business Travelers
Global Corporate Travel Security Market to Reach $19 Billion by 2034 Amid Rising …
The global corporate travel security market, valued at $11.7 billion in 2023, is poised to experience significant growth, reaching $19 billion by 2034 at a CAGR of 4.6%, according to the latest industry report. Access an overview of significant conclusions from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=75325 Industry Dynamics and Growth Drivers The market is witnessing rapid growth due to increased concerns over the safety and well-being of business travelers in an
Low-Calorie Food Market Expands as Consumers Shift to Healthier Lifestyles Amid Pandemic
Low-Calorie Food Market Expands as Consumers Shift to Healthier Lifestyles Amid …
The Health Crisis Driving Demand for Low-Calorie Foods According to the World Health Organization (WHO), obesity is a primary contributor to chronic ailments such as heart disease, diabetes, and high blood pressure. Alarmingly, over 42 million preschool children worldwide were classified as overweight as early as 2013, and these numbers have continued to rise. For adults, the sedentary lifestyle and stress associated with modern professional life have further exacerbated health risks,
Astaxanthin Market Forecasts Robust 10.2% Annual Growth with Significant Opportunities in Aquaculture and Dietary Supplements
Astaxanthin Market Forecasts Robust 10.2% Annual Growth with Significant Opportu …
The global market for astaxanthin, Experienced significant growth due to its increasing application across industries such as dietary supplements, animal feed, food and beverages, cosmetics, and pharmaceuticals. Valued at US$ 758.2 Mn in 2022, the market is projected to reach US$ 2001.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.2%. This impressive growth is driven by consumer demand for natural and organic products, rising health

All 5 Releases


More Releases for Stendomycin

Stendomycin Salicylate Market share will expand till 2024
A new research report by Transparency Market Research offers a comprehensive evaluation of the global Stendomycin Salicylate Market. The study, titled “Stendomycin Salicylate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”, is available for sale on the firm’s website. Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of
Stendomycin Salicylate Market share will expand till 2024
A new research report by Transparency Market Research offers a comprehensive evaluation of the global Stendomycin Salicylate Market. The study, titled “Stendomycin Salicylate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”, is available for sale on the firm’s website. Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of
TMR Releases New Report on the Stendomycin Salicylate Market 2016 - 2024
Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of the disease-causing fungus is Sphaerotheca pannosa var. rosae. The fungus is also known as Podosphaera pannosa. Rose mildew is a highly common foliar disease of roses. The visible white powdery growth can affect all parts of the plant that are above the ground. Poor-quality
Stendomycin Salicylate Market - Global Industry Analysis, Size, Share, Growth 20 …
Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of the disease-causing fungus is Sphaerotheca pannosa var. rosae. The fungus is also known as Podosphaera pannosa. Rose mildew is a highly common foliar disease of roses. The visible white powdery growth can affect all parts of the plant that are above the ground. Poor-quality
Stendomycin Salicylate Market - Global Industry Analysis, Trends, and Forecast 2 …
Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of the disease-causing fungus is Sphaerotheca pannosa var. rosae. The fungus is also known as Podosphaera pannosa. Rose mildew is a highly common foliar disease of roses. The visible white powdery growth can affect all parts of the plant that are above the ground. Poor-quality